 Cyclacel Pharmaceuticals, Inc. Nasdaq:CYCC, Nasdaq:CYCCP Cyclacel or the Company, a biopharmaceutical company developing innovative medicines based on cancer cell biology, announces that the Company will present at the BIO CEO Investor Conference at 11:15 a.m. EST on Monday, February 10, in the Wilder Room at the New York Marriott Marquis. Spiro Rombotis, President Chief Executive Officer, will provide an overview of the Company and progress in its key programs. A live webcast of the presentation will be available through the Companys website: 